ADIPOQ and obesity disorder: They highlighted the presence of a negative association between methylation at the level of specific sites of LEP and ADIPOQ promoters and the combined presence of obesity, and insulin resistance, supporting the hypothesis that epigenetic modifications could be at the basis of the development of obesity and related metabolic disorders.